🔗 Share this article

An underground economy for unapproved slimming medications is propelled by social media fitness personalities and vendors on communication apps, according to recent findings.

Experimental Drug Acquiring Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning effects. Followers are urged to message these profiles directly for source information, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with thousands of members share “before and after” images, injection guides and assertions of next-day UK delivery. Sellers promote the substance there before directing buyers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Experts Express Worries

Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in individuals injecting substances of uncertain source.

Several experts stated the popularity for retatrutide could be linked to the rising cost of approved weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate pharmaceutical, marketing, and customer regulations, potentially leading to fines, legal action or prison.

Service Reaction and Material Removal

According to the social media company, the platform has removed problematic content and prohibited associated hashtags and query recommendations. The company stated it was committed to maintaining the platform secure and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Investigations also discovered communities with up to 9,000 participants selling retatrutide using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, filled with images of weight loss, glowing testimonials and step-by-step instructions for mixing or injecting at residence.

Within minutes of entering one group, a vendor posted WhatsApp details, where the majority of transactions take place. The seller provided an guidebook and promised shipping within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about weight, health issues or previous experience.

Item Information and Costs

Inside these communities, messages show black plastic packages with postal service labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with sterile water, or ready-to-use pens usually priced at £160 for 20mg. When asked how long a injector should last, sellers give contradictory responses varying between a several days to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service said it actively moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting materials they can’t verify. Even if the science behind retatrutide is sound, these digital products may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the increase in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were produced in was sterile,” she explained.

Her staff has previously seen patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company experimental product not yet authorized … may subject patients to potentially significant health risks”.